UFP Technologies is set to release its Q4 2025 earnings, with market expectations for a 3.5% year-on-year revenue growth, a slowdown from the previous year. The company has a strong record of exceeding revenue forecasts, but its stock, along with the broader drug development inputs and services sector, has seen recent declines amidst market uncertainty. Analysts maintain a price target significantly above the current trading price despite the recent dip.
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
UFP Technologies Q4 2025 Earnings Preview: Growth, Estimates & Market Outlook - News and Statistics
UFP Technologies is set to release its Q4 2025 earnings, with market expectations for a 3.5% year-on-year revenue growth, a slowdown from the previous year. The company has a strong record of exceeding revenue forecasts, but its stock, along with the broader drug development inputs and services sector, has seen recent declines amidst market uncertainty. Analysts maintain a price target significantly above the current trading price despite the recent dip.